This case-control study analyzed the associations between breast cancer and polymorphisms in circadian clock genes (ARTNL, CLOCK, CRY2, NPAS, and PER2) and in genes of the melatonin pathway as well (AANAT and MTNR1B). This evidence concerns the gene CRY2 and breast carcinoma.